NO20021498L - Genet PRV-1 og anvendelsen av dette - Google Patents

Genet PRV-1 og anvendelsen av dette

Info

Publication number
NO20021498L
NO20021498L NO20021498A NO20021498A NO20021498L NO 20021498 L NO20021498 L NO 20021498L NO 20021498 A NO20021498 A NO 20021498A NO 20021498 A NO20021498 A NO 20021498A NO 20021498 L NO20021498 L NO 20021498L
Authority
NO
Norway
Prior art keywords
prv
gene
gene prv
Prior art date
Application number
NO20021498A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021498D0 (no
Inventor
Heike Pahl
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of NO20021498D0 publication Critical patent/NO20021498D0/no
Publication of NO20021498L publication Critical patent/NO20021498L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20021498A 1999-09-30 2002-03-26 Genet PRV-1 og anvendelsen av dette NO20021498L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (de) 1999-09-30 2000-09-29 Das gen prv-1 und dessen verwendung

Publications (2)

Publication Number Publication Date
NO20021498D0 NO20021498D0 (no) 2002-03-26
NO20021498L true NO20021498L (no) 2002-05-23

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021498A NO20021498L (no) 1999-09-30 2002-03-26 Genet PRV-1 og anvendelsen av dette

Country Status (21)

Country Link
EP (1) EP1220920A1 (cs)
JP (1) JP2003510077A (cs)
KR (1) KR20020047191A (cs)
CN (1) CN1377408A (cs)
AU (1) AU1132401A (cs)
BG (1) BG106554A (cs)
BR (1) BR0014444A (cs)
CA (1) CA2387702A1 (cs)
CZ (1) CZ20021094A3 (cs)
DE (1) DE19947010A1 (cs)
EA (1) EA200200286A1 (cs)
EE (1) EE200200168A (cs)
HR (1) HRP20020269A2 (cs)
HU (1) HUP0203080A2 (cs)
IL (1) IL148770A0 (cs)
MX (1) MXPA02002800A (cs)
NO (1) NO20021498L (cs)
PL (1) PL354184A1 (cs)
SK (1) SK4262002A3 (cs)
WO (1) WO2001023554A1 (cs)
ZA (1) ZA200202379B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
WO2013177062A2 (en) 2012-05-21 2013-11-28 Genentech, Inc. Methods for improving safety of blood-brain barrier transport
CN111094547B (zh) * 2017-06-14 2024-02-09 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） 用于纯化源自人胚胎干细胞的内胚层和胰腺内胚层细胞的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289118A1 (en) * 1997-05-06 1998-11-12 Zymogenetics, Inc. Novel tumor antigens
CA2328895A1 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
CA2348757A1 (en) * 1998-12-16 2000-06-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
ZA200202379B (en) 2003-10-29
MXPA02002800A (es) 2002-07-22
CN1377408A (zh) 2002-10-30
NO20021498D0 (no) 2002-03-26
KR20020047191A (ko) 2002-06-21
WO2001023554A1 (de) 2001-04-05
EE200200168A (et) 2003-04-15
DE19947010A1 (de) 2001-04-05
PL354184A1 (en) 2003-12-29
AU1132401A (en) 2001-04-30
CZ20021094A3 (cs) 2002-06-12
IL148770A0 (en) 2002-09-12
BG106554A (bg) 2003-01-31
EP1220920A1 (de) 2002-07-10
JP2003510077A (ja) 2003-03-18
CA2387702A1 (en) 2001-04-05
HUP0203080A2 (hu) 2002-12-28
HRP20020269A2 (en) 2003-06-30
BR0014444A (pt) 2002-06-11
EA200200286A1 (ru) 2002-12-26
SK4262002A3 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
ATE360686T1 (de) Alpha-amylase-varianten
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DE60026649D1 (de) Anzeigegerät
IL147683A0 (en) Microarrays and their manufacture
NO990296D0 (no) HPPD-genet og inhibitorer
IS6411A (is) Kaspasa tálmar og notkun þeirra
FI991206L (fi) Näytön ohjaaminen
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
ID25571A (id) Popok sekali pakai
DE60044322D1 (de) Anzeige
ID24782A (id) Popok sekali pakai
DE10084951T1 (de) Aromatisches Oligomer und dessen Verwendung
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
EP1147186A4 (en) In vitro activated gamma delta lymphocytes
DK1065277T3 (da) Alfa-amylasemutanter
NO20021305L (no) DNA-konstruksjon og dens anvendelse
DE60020757D1 (de) Flachbaugruppenträger und Leerbaugruppe
IL149679A0 (en) Nucleic acid construct and methods utilizing the same
NO20021498L (no) Genet PRV-1 og anvendelsen av dette
AU1894601A (en) Novel gene and use thereof
GB0009204D0 (en) Headstones and the like
AU5476600A (en) Gene specific arrays and the use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application